Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
46.59
-1.45 (-3.02%)
At close: Jan 16, 2026, 4:00 PM EST
47.03
+0.44 (0.94%)
After-hours: Jan 16, 2026, 6:03 PM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $6.1 billion as of January 16, 2026. Its market cap has decreased by -40.22% in one year.
Market Cap
6.10B
Enterprise Value
4.47B
1-Year Change
-40.22%
Ranking
Category
Stock Price
$46.59
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $6.10B, an increase of 341.96%. That is a compound annual growth rate of 30.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 6.10B | 0.98% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |